Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '584 is Officially Recertified

So, you'd sooner have S&L with their covertibles and price resets and possibly 1 billion shares outstanding?

Were it not for the dividends, how would you have removed the contractual obligations to them without even further dilution?

What I still remain disappointed with is the fact that PTSC didn't obtain first refusal rights from S&L to repurchase their stock when they came to sell it.

.

.

Be well

Share
New Message
Please login to post a reply